Results 271 to 280 of about 325,525 (350)

Hepatic Viral Reservoirs in Concurrent HIV and HBV: From Mechanistic Insight to Integrated Cure Strategies. [PDF]

Infect Drug Resist
Bobadilla R, MacLean F, Dave S, Blackard JT, Gianella S.   +4 more
europepmc   +1 more source

Pathogen‐reduced platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections, 2017–2024

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Pathogen reduction (PR) using amotosalen‐UVA was implemented for 100% of platelet concentrates (PCs) in France in November 2017. No bacterial testing was in place earlier. The impact of PR on the risk of transfusion‐transmitted infections (TTIs) from November 2017 to December 2022 (vs.
Syria Laperche, Virginie de la Taille, Pierre Gallian, Elodie Pouchol, Catherine Humbrecht, Alexandre Montembault, Lucile Malard, Caroline Bacquet, Marianne Asso‐Bonnet, Sophie Le Cam, Thierry Peyrard, Pierre Tiberghien   +11 more
wiley   +1 more source

Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and Spain. [PDF]

Hum Vaccin Immunother
Nikitas G, Mohy A, Duchenne M, Genovez V, Casabona G, Hennessy E, Vallejo L, Haddouche AA, Marijam A.   +8 more
europepmc   +1 more source

Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Accurate detection of transfusion‐transmissible infections, such as human immunodeficiency virus (HIV) and hepatitis C and B viruses (HCV/HBV), is critical to ensure blood safety, and screening assays must demonstrate high specificity and sensitivity.
Monica Chaves, Martina Schaetzl, Florina Pessl   +2 more
wiley   +1 more source

All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study. [PDF]

J Viral Hepat
Makuza JD, Law M, Puyat J, Ramji A, Jeong D, Morrow RL, Adu PA, Nisingizwe MP, Issanov A, Cua G, García HAV, Berabose C, Tuyishime A, Janjua NZ.   +13 more
europepmc   +1 more source

Re‐entry of donors deferred for false‐reactive screening tests in Canada: 10 years post implementation

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Canadian Blood Services implemented a re‐entry programme in 2014. Donors deferred because of false‐reactive or indeterminate screening tests can provide a specimen for re‐entry testing 6 months after their initial test, and resume donating if they test negative for all infectious markers.
Chinchin Wang, Steven J. Drews, Mark Bigham, Mindy Goldman, Sheila F. O'Brien   +4 more
wiley   +1 more source

GPX2+ tumor cells recruit LGALS1+ B cells via CCL26-CCR3 axis to promote immunosuppression and tumor progression in hepatocellular carcinoma. [PDF]

Front Immunol
Lin L, Yang S, Zhang J, Chen G, Zhou W, Chen D, Chen J.   +6 more
europepmc   +1 more source

Transfusion‐transmitted malaria in India: A national survey of epidemiology and testing practices

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Malaria still poses a public health burden in India despite ongoing elimination efforts. Blood donor screening for malaria is mandated in India, yet data on transfusion‐transmitted malaria (TTM) are lacking. We sought to evaluate testing practices for malaria, associated rates of positivity in donors and reported ...
Jeremy W. Jacobs, Nabajyoti Choudhury, Satyam Arora, Aikaj Jindal, Nidhi Bhatnagar, Abhishekh Basavarajegowda, Shamee Shastry, Tulika Chandra, David Daniel, Steven J. Drews, Evan M. Bloch   +10 more
wiley   +1 more source

Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. [PDF]

Front Immunol
Chen Z, Hu R, Ye H, Chen Q, Liu Y, Zhang X, Chen Y, Wu Y, Jin C.   +8 more
europepmc   +1 more source